Bertil Uggla

1PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 23, 2026
Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML.

Pageof 1

Frequent Collaborators

1 joint publications

Matilda Arvidsson Kvissberg

1 joint publications

Christer Nilsson

1 joint publications

Niklas Landberg

1 joint publications

Albin Österroos